Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2025-07-25 00:00:00 ET · period of report 2025-07-23 · accession 0001104659-25-070900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-07-25 | 2025-07-23 | DMAC | Von Koch Thomas | 10% | P - Purchase | $3.50 | +2.86M | 8.38M | +52% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-07-23 | P | A | 2,857,142 | $3.50 | 8,383,577 | I See Footnote 1 | — | — | (F1) These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares. |